We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03453619
Recruitment Status : Unknown
Verified August 2020 by Apellis Pharmaceuticals, Inc..
Recruitment status was:  Active, not recruiting
First Posted : March 5, 2018
Last Update Posted : September 2, 2020
Sponsor:
Information provided by (Responsible Party):
Apellis Pharmaceuticals, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Actual Primary Completion Date : April 16, 2020
Estimated Study Completion Date : December 2022
Certification/Extension First Submitted : August 27, 2020